What question did this study set out to answer?

To characterize the occurrence of new multi-organ sequelae following SARS-CoV-2 infection during different COVID-19 eras.

February 8, 2026BMC Global and Public Health0 citationsOpen Access

Characterization of post-acute multi-organ sequelae following SARS-CoV-2 Infection in the Delta and Omicron Eras in a highly boosted population

PGPeihong GuoNanyang Technological University JLJue Tao Lim LWLiang En WeeSingHealth

Puntos clave

To characterize the occurrence of new multi-organ sequelae following SARS-CoV-2 infection during different COVID-19 eras.
Analyzed prevalence of multi-organ sequelae in patients infected with SARS-CoV-2.
Compared risks across Delta and Omicron periods.
Assessed the impact of booster vaccination status on sequelae rates.
Modest rates of new multi-organ sequelae were observed across COVID-19 eras.
Booster vaccination further reduced risk during Omicron BA.4/5 and XBB periods compared to Omicron BA.1/2.

Resumen

The risks/rates of pre-specified new-incident multi-organ PASC were modest over all studied COVID-19 eras. The risk was further attenuated with booster vaccination during the Omicron BA.4/5 and XBB periods compared with the Omicron BA.1/2 period.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo